WINNIPEG, MANITOBA--(Marketwire - September 28, 2007) - Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it will be presenting at BioContact Quebec 2007 in Quebec City.
